DATOPOTAMAB DERUXTECAN

DATOPOTAMAB DERUXTECAN was reported 859 times

These side effects are most commonly reported by patients taking DATOPOTAMAB DERUXTECAN:

# Side effect Count
0 DISEASE PROGRESSION 256
1 STOMATITIS 146
2 OFF LABEL USE 122
3 DEATH 51
4 NO ADVERSE EVENT 46
5 NAUSEA 40
6 FATIGUE 33
7 DRY EYE 32
8 INTERSTITIAL LUNG DISEASE 31
9 DYSPNOEA 26
10 RASH 24
11 PNEUMONITIS 23
12 COUGH 21
13 ALOPECIA 19
14 MUCOSAL INFLAMMATION 19
15 WEIGHT DECREASED 19
16 MALAISE 18
17 KERATITIS 17
18 INFUSION RELATED REACTION 16
19 MALIGNANT NEOPLASM PROGRESSION 16
20 ORAL PAIN 15
21 VISION BLURRED 15
22 METASTASES TO LIVER 14
23 POLYNEUROPATHY 14
24 PRODUCT DOSE OMISSION ISSUE 14
25 PNEUMONIA 13
26 PYREXIA 12
27 DRUG INEFFECTIVE 11
28 LACRIMATION INCREASED 11
29 METASTASES TO CENTRAL NERVOUS SYSTEM 10
30 NEUTROPENIA 10
31 DECREASED APPETITE 9
32 PRESCRIBED UNDERDOSE 9
33 THROMBOCYTOPENIA 9
34 CATARACT 8
35 CLOSTRIDIUM COLITIS 8
36 CONSTIPATION 8
37 DIARRHOEA 8
38 LEUKOPENIA 8
39 OSTEONECROSIS OF JAW 8
40 URINARY TRACT INFECTION 8
41 ANAEMIA 7
42 ASTHENIA 7
43 DYSARTHRIA 7
44 EYE PAIN 7
45 ORAL CANDIDIASIS 7
46 PRURITUS 7
47 SEPSIS 7
48 VOMITING 7
49 LUNG NEOPLASM MALIGNANT 6
50 NEUROPATHY PERIPHERAL 6
51 OCULAR TOXICITY 6
52 PULMONARY TOXICITY 6
53 VISUAL ACUITY REDUCED 6
54 WEIGHT INCREASED 6
55 CARCINOEMBRYONIC ANTIGEN INCREASED 5
56 DEHYDRATION 5
57 DRY SKIN 5
58 EYE IRRITATION 5
59 EYE PRURITUS 5
60 FEBRILE NEUTROPENIA 5
61 NON-SMALL CELL LUNG CANCER 5
62 OCULAR HYPERAEMIA 5
63 PRODUCT PRESCRIBING ISSUE 5
64 APHTHOUS ULCER 4
65 CHEST DISCOMFORT 4
66 CORNEAL EPITHELIOPATHY 4
67 DRY MOUTH 4
68 ERYTHEMA 4
69 HEPATIC FUNCTION ABNORMAL 4
70 INFUSION SITE EXTRAVASATION 4
71 OROPHARYNGEAL PAIN 4
72 PHOTOPHOBIA 4
73 RASH PRURITIC 4
74 RESPIRATORY FAILURE 4
75 RHINORRHOEA 4
76 SEIZURE 4
77 TUMOUR MARKER INCREASED 4
78 UNDERDOSE 4
79 VISUAL IMPAIRMENT 4
80 ABDOMINAL PAIN 3
81 ACUTE RESPIRATORY FAILURE 3
82 AMYLASE INCREASED 3
83 BACK PAIN 3
84 CEREBRAL HAEMORRHAGE 3
85 CONJUNCTIVITIS 3
86 DRUG INTOLERANCE 3
87 DYSPHAGIA 3
88 HEPATIC ENZYME INCREASED 3
89 HYPOAESTHESIA 3
90 HYPOTENSION 3
91 ILLNESS 3
92 INFLAMMATION 3
93 METASTASES TO BONE 3
94 METASTASES TO LUNG 3
95 NEURALGIA 3
96 OROPHARYNGEAL DISCOMFORT 3
97 PERONEAL NERVE PALSY 3
98 PLEURAL EFFUSION 3
99 PNEUMOMEDIASTINUM 3
100 PULMONARY EMBOLISM 3
101 RASH MACULO-PAPULAR 3
102 RENAL FAILURE 3
103 SOMNOLENCE 3
104 TASTE DISORDER 3
105 THERAPY CHANGE 3
106 TOXICITY TO VARIOUS AGENTS 3
107 ABNORMAL SENSATION IN EYE 2
108 ACUTE MYOCARDIAL INFARCTION 2
109 ADVERSE DRUG REACTION 2
110 ADVERSE EVENT 2
111 AGEUSIA 2
112 AKATHISIA 2
113 ANAPHYLACTIC REACTION 2
114 ASCITES 2
115 ASPARTATE AMINOTRANSFERASE INCREASED 2
116 BALANCE DISORDER 2
117 BLINDNESS 2
118 BLISTER 2
119 BLOOD BILIRUBIN INCREASED 2
120 BODY HEIGHT INCREASED 2
121 CANDIDA INFECTION 2
122 CARDIAC FAILURE 2
123 CATHETER SITE INFECTION 2
124 CEREBROVASCULAR ACCIDENT 2
125 CHEST PAIN 2
126 CHILLS 2
127 CIRCULATORY COLLAPSE 2
128 COMPRESSION FRACTURE 2
129 CORNEAL EROSION 2
130 CYTOPENIA 2
131 DENTAL CARIES 2
132 DIZZINESS 2
133 DYSGEUSIA 2
134 DYSKINESIA 2
135 ENCEPHALOPATHY 2
136 ENTEROCOLITIS 2
137 EPILEPSY 2
138 EYE DISCHARGE 2
139 EYE DISORDER 2
140 FACIAL PARALYSIS 2
141 FEEDING DISORDER 2
142 FEELING ABNORMAL 2
143 FEELING DRUNK 2
144 GASTROINTESTINAL DISORDER 2
145 GLOSSODYNIA 2
146 GRANULOMA 2
147 HEADACHE 2
148 HOSPITALISATION 2
149 HYPERGLYCAEMIA 2
150 HYPERTRANSAMINASAEMIA 2
151 HYPONATRAEMIA 2
152 HYPOXIA 2
153 ILL-DEFINED DISORDER 2
154 INCORRECT DOSE ADMINISTERED 2
155 INFUSION SITE PAIN 2
156 INFUSION SITE SWELLING 2
157 LUNG DISORDER 2
158 LUNG OPACITY 2
159 LYMPHANGIOSIS CARCINOMATOSA 2
160 MADAROSIS 2
161 MALIGNANT ASCITES 2
162 MALIGNANT PLEURAL EFFUSION 2
163 MENINGITIS 2
164 METASTASES TO MENINGES 2
165 METASTASES TO SKIN 2
166 METASTASIS 2
167 MUSCULOSKELETAL CHEST PAIN 2
168 NASOPHARYNGITIS 2
169 NEOPLASM PROGRESSION 2
170 NERVOUSNESS 2
171 NEUTROPHIL COUNT DECREASED 2
172 NON-SMALL CELL LUNG CANCER STAGE IV 2
173 OEDEMA PERIPHERAL 2
174 ORAL DISCOMFORT 2
175 PAIN IN EXTREMITY 2
176 PAIN OF SKIN 2
177 PANCYTOPENIA 2
178 PERIODONTAL DISEASE 2
179 PHARYNGEAL PARAESTHESIA 2
180 PLATELET COUNT DECREASED 2
181 PNEUMOCYSTIS JIROVECII PNEUMONIA 2
182 PNEUMONIA ASPIRATION 2
183 PNEUMONIA BACTERIAL 2
184 PRODUCT USE ISSUE 2
185 SEPTIC SHOCK 2
186 SKIN BURNING SENSATION 2
187 SKIN EXFOLIATION 2
188 SKIN IRRITATION 2
189 SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY 2
190 SURGERY 2
191 SWELLING 2
192 TACHYCARDIA 2
193 THERAPEUTIC RESPONSE UNEXPECTED 2
194 THERAPY CESSATION 2
195 THROAT IRRITATION 2
196 THROAT TIGHTNESS 2
197 ULCERATIVE KERATITIS 2
198 ABDOMINAL DISTENSION 1
199 ABDOMINAL PAIN LOWER 1
200 ABDOMINAL PAIN UPPER 1
201 ABDOMINAL SEPSIS 1
202 ACUTE KIDNEY INJURY 1
203 ALANINE AMINOTRANSFERASE INCREASED 1
204 ALLERGIC RESPIRATORY DISEASE 1
205 AMNESIA 1
206 ANAL ULCER 1
207 ANAPHYLACTIC SHOCK 1
208 ANGULAR CHEILITIS 1
209 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1
210 ANURIA 1
211 ATYPICAL PNEUMONIA 1
212 BACTERAEMIA 1
213 BLOOD SODIUM ABNORMAL 1
214 BONE PAIN 1
215 BREAST CANCER METASTATIC 1
216 BREAST HAEMORRHAGE 1
217 BREAST PAIN 1
218 CARBOHYDRATE ANTIGEN 15-3 INCREASED 1
219 CARDIAC ARREST 1
220 CARDIAC FAILURE CONGESTIVE 1
221 CENTRAL NERVOUS SYSTEM LESION 1
222 CLOSTRIDIUM DIFFICILE COLITIS 1
223 COLITIS 1
224 COMPLETED SUICIDE 1
225 CONDITION AGGRAVATED 1
226 CONFUSIONAL STATE 1
227 CONJUNCTIVAL HAEMORRHAGE 1
228 CONJUNCTIVITIS VIRAL 1
229 CORNEAL TOXICITY 1
230 CORONARY ARTERY DISEASE 1
231 CORONAVIRUS INFECTION 1
232 CORONAVIRUS TEST POSITIVE 1
233 CYSTITIS HAEMORRHAGIC 1
234 CYTOKINE RELEASE SYNDROME 1
235 DACRYOSTENOSIS ACQUIRED 1
236 DEAFNESS 1
237 DEPRESSION 1
238 DIABETIC KETOACIDOSIS 1
239 DISABILITY 1
240 DISCOURAGEMENT 1
241 DISSEMINATED INTRAVASCULAR COAGULATION 1
242 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
243 DRUG-INDUCED LIVER INJURY 1
244 DUODENAL PERFORATION 1
245 DYSCHROMATOPSIA 1
246 DYSPEPSIA 1
247 DYSPHONIA 1
248 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1
249 EATING DISORDER 1
250 EMOTIONAL DISORDER 1
251 ENCEPHALITIS 1
252 ERYTHEMA MULTIFORME 1
253 EXFOLIATIVE RASH 1
254 EYE SWELLING 1
255 EYE SYMPTOM 1
256 FAECES SOFT 1
257 FALL 1
258 FEELING HOT 1
259 FLUID RETENTION 1
260 FRACTURE 1
261 FUNGAL PHARYNGITIS 1
262 GAIT INABILITY 1
263 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
264 GENERAL PHYSICAL HEALTH DETERIORATION 1
265 GENITAL ULCERATION 1
266 HAEMATOTOXICITY 1
267 HAEMORRHAGE 1
268 HEART RATE DECREASED 1
269 HEPATIC FAILURE 1
270 HERPES OPHTHALMIC 1
271 HERPES ZOSTER 1
272 HORDEOLUM 1
273 HOSPICE CARE 1
274 HYPERSENSITIVITY 1
275 HYPOACUSIS 1
276 HYPOCALCAEMIA 1
277 HYPOKALAEMIA 1
278 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1
279 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
280 INCORRECT DRUG ADMINISTRATION RATE 1
281 INCORRECT PRODUCT FORMULATION ADMINISTERED 1
282 INFECTION 1
283 INFECTIOUS IRIDOCYCLITIS 1
284 INFLUENZA LIKE ILLNESS 1
285 INFUSION RELATED HYPERSENSITIVITY REACTION 1
286 INFUSION SITE ERYTHEMA 1
287 INFUSION SITE IRRITATION 1
288 INFUSION SITE PRURITUS 1
289 INFUSION SITE RASH 1
290 INJECTION SITE ERYTHEMA 1
291 INJECTION SITE REACTION 1
292 INSOMNIA 1
293 INSURANCE ISSUE 1
294 INTENTIONAL PRODUCT USE ISSUE 1
295 INTESTINAL PERFORATION 1
296 INTRAOCULAR PRESSURE INCREASED 1
297 JAUNDICE CHOLESTATIC 1
298 LACTIC ACIDOSIS 1
299 LARYNGEAL DISCOMFORT 1
300 LARYNGOPHARYNGITIS 1
301 LEUKOCYTOSIS 1
302 LEUKOENCEPHALOPATHY 1
303 LIP SWELLING 1
304 LIQUID PRODUCT PHYSICAL ISSUE 1
305 LIVER FUNCTION TEST ABNORMAL 1
306 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1
307 LYMPH NODE PAIN 1
308 MALIGNANT NEOPLASM OF SPINAL CORD 1
309 MELAENA 1
310 MENTAL DISORDER 1
311 METASTASES TO PERITONEUM 1
312 METASTASES TO PLEURA 1
313 MIGRAINE 1
314 MOUTH ULCERATION 1
315 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
316 MUSCULAR WEAKNESS 1
317 MUSCULOSKELETAL PAIN 1
318 MYALGIA 1
319 MYELODYSPLASTIC SYNDROME 1
320 MYELOSUPPRESSION 1
321 MYOCARDIAL INFARCTION 1
322 MYOCARDIAL STRAIN IMAGING 1
323 NAIL BED DISORDER 1
324 NAIL INFECTION 1
325 NAIL OPERATION 1
326 NASAL DISCOMFORT 1
327 NECK PAIN 1
328 NEUROSIS 1
329 OCULAR DISCOMFORT 1
330 OCULAR SURFACE DISEASE 1
331 OESOPHAGITIS HAEMORRHAGIC 1
332 ONCOLOGIC COMPLICATION 1
333 ORAL PIGMENTATION 1
334 ORAL TOXICITY 1
335 OSTEOMYELITIS 1
336 OXYGEN THERAPY 1
337 PAIN 1
338 PALPITATIONS 1
339 PARAESTHESIA ORAL 1
340 PAROTID GLAND ENLARGEMENT 1
341 PD-L1 PROTEIN EXPRESSION 1
342 PELVIC FRACTURE 1
343 PERFORMANCE STATUS DECREASED 1
344 PERITONITIS BACTERIAL 1
345 PHARYNGEAL INFLAMMATION 1
346 PHARYNGEAL SWELLING 1
347 PHARYNGEAL ULCERATION 1
348 PNEUMONITIS CHEMICAL 1
349 POOR VENOUS ACCESS 1
350 POST PROCEDURAL COMPLICATION 1
351 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1
352 PROCEDURAL SHOCK 1
353 PRODUCT AVAILABILITY ISSUE 1
354 PRODUCT DISTRIBUTION ISSUE 1
355 PRODUCT DOSE OMISSION IN ERROR 1
356 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1
357 PRODUCT LEAKAGE 1
358 PRODUCT USE IN UNAPPROVED INDICATION 1
359 PRODUCTIVE COUGH 1
360 PSYCHIATRIC SYMPTOM 1
361 PULMONARY FIBROSIS 1
362 PUNCTATE KERATITIS 1
363 RASH ERYTHEMATOUS 1
364 RECTAL PROLAPSE 1
365 REFUSAL OF EXAMINATION 1
366 REFUSAL OF TREATMENT BY PATIENT 1
367 RENAL DISORDER 1
368 RENAL IMPAIRMENT 1
369 RESPIRATORY DISORDER 1
370 RESPIRATORY DISTRESS 1
371 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 1
372 RETINAL DEGENERATION 1
373 RIGHT VENTRICULAR FAILURE 1
374 ROSACEA 1
375 SALIVARY GLAND PAIN 1
376 SEASONAL ALLERGY 1
377 SEIZURE ANOXIC 1
378 SIALOADENITIS 1
379 SINUS TACHYCARDIA 1
380 SKIN DISORDER 1
381 SKIN TOXICITY 1
382 SPEECH DISORDER 1
383 SUPRAVENTRICULAR TACHYCARDIA 1
384 SUSPECTED OFF LABEL USE 1
385 SWELLING FACE 1
386 SWOLLEN TONGUE 1
387 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 1
388 THERAPY NON-RESPONDER 1
389 THROMBOSIS 1
390 TONGUE DISCOLOURATION 1
391 TREATMENT FAILURE 1
392 TREATMENT NONCOMPLIANCE 1
393 TROPONIN 1
394 TROPONIN I INCREASED 1
395 TROPONIN INCREASED 1
396 TUMOUR INFLAMMATION 1
397 TUMOUR PAIN 1
398 URINARY BLADDER RUPTURE 1
399 VARICELLA 1
400 VASCULAR PAIN 1
401 VEIN DISORDER 1
402 VITREOUS FLOATERS 1
403 VULVOVAGINAL PRURITUS 1
404 WHEEZING 1
405 WHITE BLOOD CELL COUNT DECREASED 1
406 WOUND INFECTION 1
407 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1
408 XEROSIS 1